ENTRY       D00270                      Drug
NAME        Chlorpromazine (USP/INN);
            Thorazine (TN)
FORMULA     C17H19ClN2S
EXACT_MASS  318.0957
MOL_WEIGHT  318.8642
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01465  alpha-Adrenergic receptor antagonist
               DG01460  alpha2-Adrenergic receptor antagonist
            Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
             DG01491  Muscarinic cholinergic receptor antagonist
             DG03200  Antipsychotic agent
              DG01905  Phenothiazine antipsychotics
            Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
REMARK      Same as: C06906
            ATC code: N05AA01
            Chemical structure group: DG00867
            Product (DG00867): D00789<JP/US> D04034<JP>
EFFICACY    Antipsychotic, Anti-emetic
COMMENT     Phenothiazine derivative
TARGET      HTR2 [HSA:3356 3357 3358] [KO:K04157]
            HRH1 [HSA:3269] [KO:K04149]
            ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
            DRD2 [HSA:1813] [KO:K04145]
            CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]
  PATHWAY   hsa04080(1128+1129+1131+1132+1133+150+151+152+1813+3269+3356+3357+3358)  Neuroactive ligand-receptor interaction
            hsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse
            hsa04726(3356+3357+3358)  Serotonergic synapse
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION CYP inhibition: CYP2D6 [HSA:1565]
STR_MAP     map07028  Antipsychotics
            map07029  Antipsychotics - phenothiazines
            map07048  Antimigraines
            map07212  Histamine H1 receptor antagonists
            map07213  Dopamine receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AA Phenothiazines with aliphatic side-chain
                 N05AA01 Chlorpromazine
                  D00270  Chlorpromazine (USP/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01460  alpha2-Adrenergic receptor antagonist
                 DG00867  Chlorpromazine
                  D00270  Chlorpromazine
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00867  Chlorpromazine
                 D00270  Chlorpromazine
              DG01491  Muscarinic cholinergic receptor antagonist
               DG00867  Chlorpromazine
                D00270  Chlorpromazine
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00867  Chlorpromazine
                 D00270  Chlorpromazine
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00867  Chlorpromazine
                 D00270  Chlorpromazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00867  Chlorpromazine
                D00270  Chlorpromazine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00867  Chlorpromazine
                D00270  Chlorpromazine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Acetylcholine (muscarinic)
                CHRM
                 D00270  Chlorpromazine (USP/INN)
               Adrenaline
                ADRA2
                 D00270  Chlorpromazine (USP/INN)
               Dopamine
                DRD2
                 D00270  Chlorpromazine (USP/INN)
               Histamine
                HRH1
                 D00270  Chlorpromazine (USP/INN)
               Serotonin
                HTR2
                 D00270  Chlorpromazine (USP/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00270
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01460  alpha2-Adrenergic receptor antagonist
                 DG00867  Chlorpromazine
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00867  Chlorpromazine
              DG01491  Muscarinic cholinergic receptor antagonist
               DG00867  Chlorpromazine
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00867  Chlorpromazine
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00867  Chlorpromazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00867  Chlorpromazine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00867  Chlorpromazine
DBLINKS     CAS: 50-53-3
            PubChem: 7847336
            ChEBI: 3647
            PDB-CCD: Z80
            LigandBox: D00270
            NIKKAJI: J2.794D
ATOM        21
            1   C8x C     3.4300  -16.7300
            2   C8x C     3.4300  -18.1300
            3   C8x C     4.6424  -18.8300
            4   C8y C     5.8549  -18.1300
            5   C8y C     5.8549  -16.7300
            6   C8x C     4.6424  -16.0300
            7   S2x S     7.0673  -18.8300
            8   C8y C     8.2797  -18.1300
            9   C8y C     8.2797  -16.7300
            10  N4y N     7.0673  -16.0300
            11  C8x C     9.4922  -18.8300
            12  C8x C    10.7046  -18.1300
            13  C8y C    10.7046  -16.7300
            14  C8x C     9.4922  -16.0300
            15  C1b C     7.0673  -14.6300
            16  C1b C     8.2818  -13.9288
            17  C1b C     9.4783  -14.6198
            18  N1c N    10.6651  -13.9346
            19  C1a C    11.8566  -14.6228
            20  C1a C    10.6653  -12.5302
            21  X   Cl   11.9211  -16.0277
BOND        23
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    8  11 2
            13   11  12 1
            14   12  13 2
            15   13  14 1
            16    9  14 2
            17   10  15 1
            18   15  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   18  20 1
            23   13  21 1
///
